Drug intelligence / Profile preview

SM70EE

Development stage
Unknown
Lead developer
Korea Institute of Ocean Science and Technology
Administration
Oral
01

Overview

SM70EE is a standardized **70% ethanol extract of Spirulina maxima**, a marine microalga. It is under investigation for its potential cognitive benefits, particularly for improving memory in older adults with **mild cognitive impairment (MCI)**. SM70EE demonstrates antioxidant effects, is thought to mitigate memory loss possibly by reducing hippocampal beta-amyloid (Aβ1-42) accumulation, inhibiting amyloid precursor protein processing, and modulating synaptic and neurotrophic pathways. Clinical trials have reported **statistically significant improvements in visual learning, visual working memory, and vocabulary** in MCI patients over 12 weeks, with an excellent safety profile. Preclinical studies suggest mechanisms involving antioxidative action, acetylcholinesterase inhibition, enhanced brain-derived neurotrophic factor (BDNF), and modulation of neuroinflammation.

Other names
Spirulina maxima 70% ethanol extract
02

Targets

CREB (Cyclic AMP response element-binding protein)PARP1 (Poly (adp-ribose) polymerase 1)GSK3 (Glycogen synthase kinase 3 beta)BDNF (Brain-derived neurotrophic factor)Acetylcholinesterase

Beyond the preview

Go deeper on SM70EE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SM70EE.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call